ALKERMES PLC (ALKS) Stock Fundamental Analysis

NASDAQ:ALKS • IE00B56GVS15

33.16 USD
-0.13 (-0.39%)
At close: Feb 13, 2026
33.16 USD
0 (0%)
After Hours: 2/13/2026, 4:51:37 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to ALKS. ALKS was compared to 523 industry peers in the Biotechnology industry. ALKS scores excellent points on both the profitability and health parts. This is a solid base for a good stock. ALKS has a correct valuation and a medium growth rate. These ratings could make ALKS a good candidate for quality investing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • ALKS had positive earnings in the past year.
  • ALKS had a positive operating cash flow in the past year.
  • In multiple years ALKS reported negative net income over the last 5 years.
  • Each year in the past 5 years ALKS had a positive operating cash flow.
ALKS Yearly Net Income VS EBIT VS OCF VS FCFALKS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 14.57%, ALKS belongs to the top of the industry, outperforming 95.22% of the companies in the same industry.
  • ALKS has a Return On Equity of 19.58%. This is amongst the best in the industry. ALKS outperforms 95.79% of its industry peers.
  • ALKS has a Return On Invested Capital of 16.22%. This is amongst the best in the industry. ALKS outperforms 96.37% of its industry peers.
Industry RankSector Rank
ROA 14.57%
ROE 19.58%
ROIC 16.22%
ROA(3y)8.82%
ROA(5y)3.68%
ROE(3y)13.16%
ROE(5y)4.95%
ROIC(3y)N/A
ROIC(5y)N/A
ALKS Yearly ROA, ROE, ROICALKS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

  • ALKS's Profit Margin of 22.30% is amongst the best of the industry. ALKS outperforms 94.46% of its industry peers.
  • ALKS's Operating Margin of 23.59% is amongst the best of the industry. ALKS outperforms 95.60% of its industry peers.
  • Looking at the Gross Margin, with a value of 86.04%, ALKS belongs to the top of the industry, outperforming 88.72% of the companies in the same industry.
  • In the last couple of years the Gross Margin of ALKS has remained more or less at the same level.
Industry RankSector Rank
OM 23.59%
PM (TTM) 22.3%
GM 86.04%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.43%
GM growth 5Y-0.08%
ALKS Yearly Profit, Operating, Gross MarginsALKS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so ALKS is creating value.
  • ALKS has less shares outstanding than it did 1 year ago.
  • ALKS has more shares outstanding than it did 5 years ago.
  • ALKS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ALKS Yearly Shares OutstandingALKS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
ALKS Yearly Total Debt VS Total AssetsALKS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

  • ALKS has an Altman-Z score of 6.88. This indicates that ALKS is financially healthy and has little risk of bankruptcy at the moment.
  • ALKS has a better Altman-Z score (6.88) than 76.67% of its industry peers.
  • There is no outstanding debt for ALKS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 6.88
ROIC/WACC2.08
WACC7.8%
ALKS Yearly LT Debt VS Equity VS FCFALKS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

  • A Current Ratio of 3.67 indicates that ALKS has no problem at all paying its short term obligations.
  • ALKS has a Current ratio (3.67) which is comparable to the rest of the industry.
  • ALKS has a Quick Ratio of 3.27. This indicates that ALKS is financially healthy and has no problem in meeting its short term obligations.
  • ALKS has a Quick ratio of 3.27. This is comparable to the rest of the industry: ALKS outperforms 41.49% of its industry peers.
Industry RankSector Rank
Current Ratio 3.67
Quick Ratio 3.27
ALKS Yearly Current Assets VS Current LiabilitesALKS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 19.71% over the past year.
  • The Earnings Per Share has been growing by 32.50% on average over the past years. This is a very strong growth
  • Looking at the last year, ALKS shows a small growth in Revenue. The Revenue has grown by 1.08% in the last year.
  • The Revenue has been growing slightly by 5.87% on average over the past years.
EPS 1Y (TTM)19.71%
EPS 3Y54.92%
EPS 5Y32.5%
EPS Q2Q%-31.94%
Revenue 1Y (TTM)1.08%
Revenue growth 3Y9.89%
Revenue growth 5Y5.87%
Sales Q2Q%4.24%

3.2 Future

  • ALKS is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.24% yearly.
  • Based on estimates for the next years, ALKS will show a small growth in Revenue. The Revenue will grow by 7.98% on average per year.
EPS Next Y-48.45%
EPS Next 2Y-28.14%
EPS Next 3Y-18.85%
EPS Next 5Y4.24%
Revenue Next Year-2.41%
Revenue Next 2Y9.66%
Revenue Next 3Y7.48%
Revenue Next 5Y7.98%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALKS Yearly Revenue VS EstimatesALKS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 1B 2B 3B
ALKS Yearly EPS VS EstimatesALKS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 13.37, the valuation of ALKS can be described as correct.
  • ALKS's Price/Earnings ratio is rather cheap when compared to the industry. ALKS is cheaper than 96.94% of the companies in the same industry.
  • ALKS's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.97.
  • Based on the Price/Forward Earnings ratio of 22.15, the valuation of ALKS can be described as rather expensive.
  • 93.12% of the companies in the same industry are more expensive than ALKS, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.96, ALKS is valued a bit cheaper.
Industry RankSector Rank
PE 13.37
Fwd PE 22.15
ALKS Price Earnings VS Forward Price EarningsALKS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • 97.32% of the companies in the same industry are more expensive than ALKS, based on the Enterprise Value to EBITDA ratio.
  • ALKS's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ALKS is cheaper than 98.28% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.15
EV/EBITDA 10
ALKS Per share dataALKS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • ALKS has a very decent profitability rating, which may justify a higher PE ratio.
  • ALKS's earnings are expected to decrease with -18.86% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.41
EPS Next 2Y-28.14%
EPS Next 3Y-18.85%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • ALKS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALKERMES PLC

NASDAQ:ALKS (2/13/2026, 4:51:37 PM)

After market: 33.16 0 (0%)

33.16

-0.13 (-0.39%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-12
Earnings (Next)04-29
Inst Owners105.82%
Inst Owner Change-1.38%
Ins Owners1.48%
Ins Owner Change4.25%
Market Cap5.48B
Revenue(TTM)1.52B
Net Income(TTM)339.32M
Analysts80.87
Price Target44.69 (34.77%)
Short Float %13.38%
Short Ratio11.25
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)66.1%
Min EPS beat(2)59.84%
Max EPS beat(2)72.36%
EPS beat(4)4
Avg EPS beat(4)43.68%
Min EPS beat(4)12.02%
Max EPS beat(4)72.36%
EPS beat(8)4
Avg EPS beat(8)10.27%
EPS beat(12)8
Avg EPS beat(12)42.89%
EPS beat(16)11
Avg EPS beat(16)151.46%
Revenue beat(2)2
Avg Revenue beat(2)10.32%
Min Revenue beat(2)8.51%
Max Revenue beat(2)12.13%
Revenue beat(4)3
Avg Revenue beat(4)7.62%
Min Revenue beat(4)-1.19%
Max Revenue beat(4)12.13%
Revenue beat(8)4
Avg Revenue beat(8)3.11%
Revenue beat(12)7
Avg Revenue beat(12)3.8%
Revenue beat(16)10
Avg Revenue beat(16)3.09%
PT rev (1m)-0.14%
PT rev (3m)0.18%
EPS NQ rev (1m)-3.14%
EPS NQ rev (3m)-3.13%
EPS NY rev (1m)-0.79%
EPS NY rev (3m)-0.83%
Revenue NQ rev (1m)0.48%
Revenue NQ rev (3m)0.66%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.2%
Valuation
Industry RankSector Rank
PE 13.37
Fwd PE 22.15
P/S 3.6
P/FCF 11.15
P/OCF 10.13
P/B 3.16
P/tB 3.32
EV/EBITDA 10
EPS(TTM)2.48
EY7.48%
EPS(NY)1.5
Fwd EY4.52%
FCF(TTM)2.98
FCFY8.97%
OCF(TTM)3.27
OCFY9.87%
SpS9.21
BVpS10.5
TBVpS9.99
PEG (NY)N/A
PEG (5Y)0.41
Graham Number24.2
Profitability
Industry RankSector Rank
ROA 14.57%
ROE 19.58%
ROCE 19.34%
ROIC 16.22%
ROICexc 40.45%
ROICexgc 45.58%
OM 23.59%
PM (TTM) 22.3%
GM 86.04%
FCFM 32.29%
ROA(3y)8.82%
ROA(5y)3.68%
ROE(3y)13.16%
ROE(5y)4.95%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.43%
GM growth 5Y-0.08%
F-Score6
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 163.07%
Cap/Sales 3.25%
Interest Coverage 250
Cash Conversion 138.93%
Profit Quality 144.77%
Current Ratio 3.67
Quick Ratio 3.27
Altman-Z 6.88
F-Score6
WACC7.8%
ROIC/WACC2.08
Cap/Depr(3y)76.88%
Cap/Depr(5y)63.55%
Cap/Sales(3y)2.83%
Cap/Sales(5y)2.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)19.71%
EPS 3Y54.92%
EPS 5Y32.5%
EPS Q2Q%-31.94%
EPS Next Y-48.45%
EPS Next 2Y-28.14%
EPS Next 3Y-18.85%
EPS Next 5Y4.24%
Revenue 1Y (TTM)1.08%
Revenue growth 3Y9.89%
Revenue growth 5Y5.87%
Sales Q2Q%4.24%
Revenue Next Year-2.41%
Revenue Next 2Y9.66%
Revenue Next 3Y7.48%
Revenue Next 5Y7.98%
EBIT growth 1Y-17.8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-2.93%
EBIT Next 3Y5.58%
EBIT Next 5Y12.64%
FCF growth 1Y93.4%
FCF growth 3Y76.56%
FCF growth 5YN/A
OCF growth 1Y83.22%
OCF growth 3Y62.84%
OCF growth 5Y43.53%

ALKERMES PLC / ALKS FAQ

What is the fundamental rating for ALKS stock?

ChartMill assigns a fundamental rating of 6 / 10 to ALKS.


What is the valuation status of ALKERMES PLC (ALKS) stock?

ChartMill assigns a valuation rating of 6 / 10 to ALKERMES PLC (ALKS). This can be considered as Fairly Valued.


Can you provide the profitability details for ALKERMES PLC?

ALKERMES PLC (ALKS) has a profitability rating of 7 / 10.


Can you provide the expected EPS growth for ALKS stock?

The Earnings per Share (EPS) of ALKERMES PLC (ALKS) is expected to decline by -48.45% in the next year.